China Vanke (H) (2202) Earnings: June Contracted Sales Hit 25.1B Yuan, YTD Sales Down 38%

China Vanke (H) on Smartkarma

Independent analysts on Smartkarma are closely watching China Vanke (H) amidst growing concerns. Fern Wang, in their research report titled “China Vanke: Should Investors Be Worried?“, highlights the company’s declining contract sales, cash position, and financing ability. Insurers have raised red flags, leading to increased scrutiny on Vanke’s debt rollover. Despite assurances of having enough funding for upcoming obligations and securing a syndication loan, the company’s performance continues to raise doubts, with no signs of improvement in sight.

A look at China Vanke (H) Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Vanke (H) seems to be well positioned for long-term success based on the Smartkarma Smart Scores provided. With top scores in both Value and Dividend, the company showcases strong fundamentals and a commitment to rewarding its investors. However, the lower scores in Growth and Resilience suggest some areas for potential improvement. Despite this, the company’s Momentum score indicates positive market sentiment and potential for future growth.

China Vanke Co., Ltd. is a prominent property development company known for its focus on residential properties in major Chinese cities like Shenzhen, Shanghai, and Beijing. The high scores in Value and Dividend highlight its stability and attractiveness to investors, while the lower scores in Growth and Resilience could signal areas where strategic adjustments may be needed to further enhance its long-term performance.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma